Research programs provide mental health resources for area youth September 25, 2024 • 8:53 a.m. The Trauma Focused Cognitive Behavioral Therapy and Behavioral Activation programs are free and designed for eligible participants between the ages of eight and 20 who are not currently dealing with a mental health emergency such as psychosis or immediately suicidal thoughts. Spotlight on Dr. Ramkumar Menon: Driven by the impact of translational research, therapies to prevent pre-term birth September 19, 2024 • 11:24 a.m. All pregnant mothers hope for the healthy, full-term delivery of their baby. But for many mothers, that's not how things go. UTMB Doctoral Student Receives NCI Award for AI-Driven Early Oral Cancer Detection Research September 17, 2024 • 11:43 a.m. Paula Villarreal is only the second University of Texas Medical Branch doctoral student to be awarded the F99/K00 Grant, and the first to receive it specifically under the National Cancer Institute’s Predoctoral to Postdoctoral Fellow Transition grant. UTMB Awarded a $15.6 Million/year NIH Grant for Three Years of Vaccine Development with Partners September 16, 2024 • 10:08 a.m. The University of Texas Medical Branch recently received a three-year award of $15.6 million per year from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) to conduct cutting-edge research aimed at developing vaccines and monoclonal antibodies (mAbs) to combat high-priority viral pathogens. Spotlight on Dr. Alan Landay: A career built on curiosity and collaboration August 26, 2024 • 4:14 p.m. When you talk to Dr. Alan Landay about his career, a palpable, positive energy fills the room as he smiles and takes you through his decades-long journey that has now brought him to the University of Texas Medical Branch. UTMB receives $4.1 million grant to study drugs capable of treating a fetus in utero August 21, 2024 • 10:46 a.m. The National Institutes of Health awarded University of Texas Medical Branch researchers more than $4.1 million over the next five years to test an anti-inflammatory drug capable of reaching and treating a fetus during pregnancy to prevent preterm birth. New small-molecule drug may help people stay strong as they age August 15, 2024 • 11:21 a.m. New research out of the University of Texas Medial Branch holds promise for helping people maintain strength and mobility as they age. Organ-on-a-chip technology to help advance women's, pregnancy health August 13, 2024 • 10:00 a.m. In the video, Dr. Ramkumar Menon discusses the technology that allows scientists to study gestational disease using miniature organ models made up of human cells embedded onto silicon surfaces. UTMB study shows success with new vaccines to prevent Andes virus August 5, 2024 • 2:53 p.m. A mRNA vaccine protects against Andes virus in an animal model, according to a new study by UTMB scientists. Andes virus is a prominent rodent-borne virus in South America and has human fatality rates up to 30 percent. Mexican American who use both English, Spanish exhibit better cognitive function July 26, 2024 • 10:00 a.m. Dr. Brian Downer speaks about a study which demonstrates that Mexican American adults aged 65 and older who use both English and Spanish more equally exhibit better cognitive function compared to those who predominantly use one language. «12345…10» Search Categories Awards & Accolades Education Faculty/Staff News Health Care In The News Innovations News Releases Top News UTMB Research Contact Media Team UTMB Experts
Research programs provide mental health resources for area youth September 25, 2024 • 8:53 a.m. The Trauma Focused Cognitive Behavioral Therapy and Behavioral Activation programs are free and designed for eligible participants between the ages of eight and 20 who are not currently dealing with a mental health emergency such as psychosis or immediately suicidal thoughts.
Spotlight on Dr. Ramkumar Menon: Driven by the impact of translational research, therapies to prevent pre-term birth September 19, 2024 • 11:24 a.m. All pregnant mothers hope for the healthy, full-term delivery of their baby. But for many mothers, that's not how things go.
UTMB Doctoral Student Receives NCI Award for AI-Driven Early Oral Cancer Detection Research September 17, 2024 • 11:43 a.m. Paula Villarreal is only the second University of Texas Medical Branch doctoral student to be awarded the F99/K00 Grant, and the first to receive it specifically under the National Cancer Institute’s Predoctoral to Postdoctoral Fellow Transition grant.
UTMB Awarded a $15.6 Million/year NIH Grant for Three Years of Vaccine Development with Partners September 16, 2024 • 10:08 a.m. The University of Texas Medical Branch recently received a three-year award of $15.6 million per year from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) to conduct cutting-edge research aimed at developing vaccines and monoclonal antibodies (mAbs) to combat high-priority viral pathogens.
Spotlight on Dr. Alan Landay: A career built on curiosity and collaboration August 26, 2024 • 4:14 p.m. When you talk to Dr. Alan Landay about his career, a palpable, positive energy fills the room as he smiles and takes you through his decades-long journey that has now brought him to the University of Texas Medical Branch.
UTMB receives $4.1 million grant to study drugs capable of treating a fetus in utero August 21, 2024 • 10:46 a.m. The National Institutes of Health awarded University of Texas Medical Branch researchers more than $4.1 million over the next five years to test an anti-inflammatory drug capable of reaching and treating a fetus during pregnancy to prevent preterm birth.
New small-molecule drug may help people stay strong as they age August 15, 2024 • 11:21 a.m. New research out of the University of Texas Medial Branch holds promise for helping people maintain strength and mobility as they age.
Organ-on-a-chip technology to help advance women's, pregnancy health August 13, 2024 • 10:00 a.m. In the video, Dr. Ramkumar Menon discusses the technology that allows scientists to study gestational disease using miniature organ models made up of human cells embedded onto silicon surfaces.
UTMB study shows success with new vaccines to prevent Andes virus August 5, 2024 • 2:53 p.m. A mRNA vaccine protects against Andes virus in an animal model, according to a new study by UTMB scientists. Andes virus is a prominent rodent-borne virus in South America and has human fatality rates up to 30 percent.
Mexican American who use both English, Spanish exhibit better cognitive function July 26, 2024 • 10:00 a.m. Dr. Brian Downer speaks about a study which demonstrates that Mexican American adults aged 65 and older who use both English and Spanish more equally exhibit better cognitive function compared to those who predominantly use one language.